Congress may take on high drug prices next year


A high-profile Republican senator wants to include potential Food and Drug Administration reforms intended to lower drug prices within a larger legislative package next year.

"There is clearly a greater role for the FDA here," said Sen. Susan Collins, R-Maine, chairwoman of the Senate Special Committee on Aging, which held the first bipartisan Senate hearing on high generic drug prices Wednesday.

But which FDA reform package is another question, as Collins didn't say it would be part of the Senate's efforts to draft its own version of the 21st Century Cures Act. That bill passed the House earlier this year and contains new money for medical research and reforms to get drugs to market much faster.